☆ 4.2 Article

Engineering nano-clustered multivalent agonists to cross-link TNF receptors for cancer therapy

AGGREGATE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Multidisciplinary

An IL-12-Based Nanocytokine Safely Potentiates Anticancer Immunity through Spatiotemporal Control of Inflammation to Eradicate Advanced Cold Tumors

Pengwen Chen et al.

Summary: Researchers have developed a nanocytokine that can release active interleukin 12 (IL-12) specifically in tumor tissues, leading to localized antitumoral inflammation without causing systemic immune responses and toxicities. This strategy shows promising potential for safer and more effective immunotherapies.

ADVANCED SCIENCE (2023)

添加到收藏夹

Article Oncology

A randomized, placebo-controlled, phase 2 trial of INBRX-109 in unresectable or metastatic conventional chondrosarcoma.

Sant P. Chawla et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Logic-gated antibody pairs that selectively act on cells co-expressing two antigens

Simone C. Oostindie et al.

Summary: HexElect(R) is an approach to enhance the functional selectivity of therapeutic antibodies by promoting their clustering after binding to two different antigens on the same target cell.

NATURE BIOTECHNOLOGY (2022)

添加到收藏夹

Meeting Abstract Hematology

A Phase 1 Dose Escalation Study of Igm-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies

Elizabeth Budde et al.

BLOOD (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Engineering precision nanoparticles for drug delivery

Michael J. Mitchell et al.

Summary: The development of nanoparticles has shown promising clinical applications, overcoming the limitations of therapeutic interventions and biological barriers. Precision therapies have enhanced treatment efficacy through personalized interventions. Advancements in nanoparticle design aim to optimize drug delivery, improving efficacy in general applications and enabling tailored designs for precision applications.

NATURE REVIEWS DRUG DISCOVERY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy

Cheng-Tao Jiang et al.

Summary: The researchers developed a versatile antibody immobilization platform by conjugating antibodies onto nanoparticles, which effectively enhanced antitumor immune responses mediated by T cells, natural killer cells, and macrophages. This strategy shows promise in improving the efficacy of immunotherapy.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Dual-functional super bispecific nano-antibodies derived from monoclonal antibodies potentiate the antitumor effect of innate immune cells

Kai-Ge Chen et al.

Summary: Innate immune cells play a crucial role in tumor surveillance and elimination through their spontaneous tumoricidal effects. Dual-functional super bispecific nano-antibodies can regulate the antitumor response of innate immune cells and establish a close physical connection between effector cells and tumor cells, enhancing innate antitumor immunity in vitro and in vivo.

NANO TODAY (2021)

添加到收藏夹

Review Immunology

The OX40/OX40L Axis Regulates T Follicular Helper Cell Differentiation: Implications for Autoimmune Diseases

NanNan Fu et al.

Summary: OX40/OX40L signaling plays a crucial role in regulating Tfh cells, promoting their differentiation, survival, and helper function for B cells. However, dysregulated OX40 signaling is associated with abnormal Tfh activity that leads to autoimmune diseases.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Oncology

Interleukins in cancer: from biology to therapy

Dania Briukhovetska et al.

Summary: This article provides an update on the role of interleukins in tumor biology, highlighting their significance in cancer development, progression, and immunotherapy. Interleukins can both promote cancer growth and enhance tumor-directed immune responses, making them a valuable target for improving treatment effectiveness and reducing side effects.

NATURE REVIEWS CANCER (2021)

添加到收藏夹

Review Immunology

The role of IgG Fc receptors in antibody-dependent enhancement

Stylianos Bournazos et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity

Xinyue Qi et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Oncology

HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality

David M. Richards et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

添加到收藏夹

Review Oncology

Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox

Bora Lim et al.

CANCERS (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

The promise and challenges of immune agonist antibody development in cancer

Patrick A. Mayes et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Functional optimization of agonistic antibodies to OX40 receptor with novel Fc mutations to promote antibody multimerization

Di Zhang et al.

MABS (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo

Haipeng Liu et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions

O. S. Qureshi et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Review Immunology

Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy

Agathe Dubuisson et al.

ANTIBODIES (2017)

添加到收藏夹

Review Oncology

Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy

Silvia von Karstedt et al.

NATURE REVIEWS CANCER (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody

Di Zhang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

添加到收藏夹

Review Oncology

A fate worse than death: apoptosis as an oncogenic process

Gabriel Ichim et al.

NATURE REVIEWS CANCER (2016)

添加到收藏夹

Article Immunology

Antibodies Targeting Human OX40 Expand Effector T Cells and Block Inducible and Natural Regulatory T Cell Function

Kui S. Voo et al.

JOURNAL OF IMMUNOLOGY (2013)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Clinical targeting of the TNF and TNFR superfamilies

Michael Croft et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Polymeric human Fc-fusion proteins with modified effector functions

David N. A. Mekhaiel et al.

SCIENTIFIC REPORTS (2011)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy

Norma Lynn Fox et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2010)

添加到收藏夹

Review Immunology

The significance of OX40 and OX40L to T-cell biology and immune disease

Michael Croft et al.

IMMUNOLOGICAL REVIEWS (2009)

添加到收藏夹

Article Immunology

OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection

Silvia Piconese et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

添加到收藏夹

Article Immunology

Identification of residues in the Cμ4 domain of polymeric IgM essential for interaction with Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1)

Ashfaq Ghumra et al.

JOURNAL OF IMMUNOLOGY (2008)

添加到收藏夹

Review Oncology

The TRAIL apoptotic pathway in cancer onset, progression and therapy

Ricky W. Johnstone et al.

NATURE REVIEWS CANCER (2008)

添加到收藏夹

Review Pharmacology & Pharmacy

TRAIL death receptors and cancer therapeutics

Ying Huang et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)

添加到收藏夹

Article Hematology

OX40 costimulation turns off Foxp3+ tregs

Minh Diem Vu et al.

BLOOD (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain

Nicholas P. Morris et al.

MOLECULAR IMMUNOLOGY (2007)

添加到收藏夹

Review Immunology

Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40

K Sugamura et al.

NATURE REVIEWS IMMUNOLOGY (2004)

添加到收藏夹

Review Immunology

Signalling pathways of the TNF superfamily: A double-edged sword

BB Aggarwal

NATURE REVIEWS IMMUNOLOGY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.